Pienomial
Sanat Mohanty is an accomplished professional with extensive experience in the fields of operations and technology development. As the Founder and CEO of Pienomial since 2022, Sanat leads innovative initiatives. Previously, Sanat held significant roles at Senseonics, Incorporated from 2016 to 2022, including Vice President/Sr Director of Operations and Director of Advanced Process Development. Co-founding Inkilab Technologies Private Limited from 2012 to 2016, Sanat contributed to the startup focused on diagnostics and health systems. Sanat also served as an Associate Professor at IIT Delhi between 2010 and 2015 and gained experience as a Research Supervisor at 3M from 2001 to 2009, focusing on technology management in materials. Sanat's educational background includes a PhD in Chemical Engineering from the University of Minnesota, an MS from Louisiana State University, and a BTech from the Indian Institute of Technology, Bombay.
This person is not in any teams
Pienomial
The dream of a healthy life for everyone inspires us everyday. Recent advances in biochemistry and genomics hold the promise of realizing this dream closer than ever before. There has been an explosion in the number of new firms (and increased interest amongst established market players) investigating the potential of harnessing these advances. These new therapeutic interventions will help all of us successfully overcome existing and emerging new health challenges. Ongoing research and the resulting drugs will impact cancer, neurological diseases, auto-immune diseases, and infectious diseases in our lifetime. In this quest, every bio-pharmaceutical and medical device company needs to stay on top of this fast evolving domain from a scientific and market perspective. They also need to ensure that their operational processes for manufacturing and delivering these promising new drugs meet regulatory standards efficiently. Pienomial is a machine learning enabled platform for the bio-pharma and life sciences industries that can synthesize vast amounts of data in varying formats and turn it into actionable intelligence. By empowering our customers with real-time, data based analysis and scenario modeling, we eliminate costly human errors and present leaders with unique insights to bring clarity into their business decisions. We empower our customers across the entire value chain from drug development to delivery and beyond. By harnessing the power of the latest advances in machine learning, generative AI and other technologies, Pienomial today provides customers with the latest in scientific and market intelligence to compete effectively in the marketplace. We also help improve the effectiveness of operational processes to meet and exceed compliance standards, thereby avoiding costly recalls and negative brand impact.